Real-world apremilast use in biologic-naïve psoriatic arthritis patients. Data from Spanish clinical practice Jordi Gratacós-Masmitja; Emma Beltrán Catalán; José Luis Álvarez Vega; Ana Urruticoechea-Arana; Concepción Fito; Francisco Maceiras; Joaquín María Belzunegui Otano; Julia Fernández Melón; Eugenio Chamizo Carmona; Miguel Ángel Abad Hernández; Inmaculada Ros Vilamajó; Sonia Castro Oreiro; Eva Pascual Alfonso; Juan Carlos Torre Alonso;

Recommendations of the Mexican College of Rheumatology for the management of psoriatic arthritis Julio Casasola-Vargas; Diana Flores-Alvarado; Luis H. Silveira; Sandra Sicsik-Ayala; Greta Reyes-Cordero; Guadalupe Villanueva Quintero; Mario Amaya Guerra; Sara G. Reyes Orozco; Beatriz E. Zazueta Montiel; Roberto Hernández-Paz; Angélica Mendoza-Fuentes; Ana G. Bernard-Medina; Alejandra López Rodriguez; Rosa E. Barbosa Cobos; Rubén Burgos-Vargas; César Pacheco-Tena;

The activity of psoriatic arthritis with axial involvement correlates with the PsAID12 Jose Antonio Pinto Tasende; Carlota Laura Iñiguez Ubiaga; Victor Eliseo Quevedo Vila; Luis Fernández Dominguez; Francisco Jose Maceiras Pan; Carlos García Porrúa;